-
1
-
-
64849105830
-
WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens - Part B: Biological agents
-
V. Bouvard, R. Baan, and K. Straif et al. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens - part B: biological agents Lancet Oncol 10 2009 321 322
-
(2009)
Lancet Oncol
, vol.10
, pp. 321-322
-
-
Bouvard, V.1
Baan, R.2
Straif, K.3
-
2
-
-
32644444748
-
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus
-
S.J. Smeets, B.J. Braakhuis, and S. Abbas et al. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus Oncogene 25 2006 2558 2564
-
(2006)
Oncogene
, vol.25
, pp. 2558-2564
-
-
Smeets, S.J.1
Braakhuis, B.J.2
Abbas, S.3
-
3
-
-
77949890036
-
Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma
-
A.C. Jung, J. Briolat, and R. Millon et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma Int J Cancer 126 2010 1882 1894
-
(2010)
Int J Cancer
, vol.126
, pp. 1882-1894
-
-
Jung, A.C.1
Briolat, J.2
Millon, R.3
-
4
-
-
80052565730
-
Human papillomavirus and rising oropharyngeal cancer incidence in the United States
-
A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 2011 4294 4301
-
(2011)
J Clin Oncol
, vol.29
, pp. 4294-4301
-
-
Chaturvedi, A.K.1
Engels, E.A.2
Pfeiffer, R.M.3
-
5
-
-
84873078950
-
Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm
-
M.M. Rietbergen, C.R. Leemans, and E. Bloemena et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm Int J Cancer 132 2013 1565 1571
-
(2013)
Int J Cancer
, vol.132
, pp. 1565-1571
-
-
Rietbergen, M.M.1
Leemans, C.R.2
Bloemena, E.3
-
6
-
-
34548680936
-
Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis
-
C.C. Ragin, and E. Taioli Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis Int J Cancer 121 2007 1813 1820
-
(2007)
Int J Cancer
, vol.121
, pp. 1813-1820
-
-
Ragin, C.C.1
Taioli, E.2
-
7
-
-
77954190940
-
Human papillomavirus and survival of patients with oropharyngeal cancer
-
K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
-
(2010)
N Engl J Med
, vol.363
, pp. 24-35
-
-
Ang, K.K.1
Harris, J.2
Wheeler, R.3
-
8
-
-
84862128343
-
Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer
-
R. Mehra, K.K. Ang, and B. Burtness Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer Semin Radiat Oncol 22 2012 194 197
-
(2012)
Semin Radiat Oncol
, vol.22
, pp. 194-197
-
-
Mehra, R.1
Ang, K.K.2
Burtness, B.3
-
9
-
-
84864130994
-
Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck
-
10.1007/s12105-012-0361-8 [Review]. [Epub ahead of print]
-
A. Psyrri, C. Sasaki, M. Vassilakopoulou, G. Dimitriadis, and T. Rampias Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck Head Neck Pathol 2012 10.1007/s12105-012- 0361-8 [Review]. [Epub ahead of print]
-
(2012)
Head Neck Pathol
-
-
Psyrri, A.1
Sasaki, C.2
Vassilakopoulou, M.3
Dimitriadis, G.4
Rampias, T.5
-
10
-
-
34447097241
-
Rational bases for the development of EGFR inhibitors for cancer treatment
-
R. Bianco, T. Gelardi, and V. Damiano et al. Rational bases for the development of EGFR inhibitors for cancer treatment Int J Biochem Cell Biol 39 2007 1416 1431
-
(2007)
Int J Biochem Cell Biol
, vol.39
, pp. 1416-1431
-
-
Bianco, R.1
Gelardi, T.2
Damiano, V.3
-
11
-
-
34147178690
-
The epidermal growth factor receptor (EGFR) in head and neck cancer: Its role and treatment implications
-
M. Zimmermann, A. Zouhair, D. Azria, and M. Ozsahin The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications Radiat Oncol 1 2006 11
-
(2006)
Radiat Oncol
, vol.1
, pp. 11
-
-
Zimmermann, M.1
Zouhair, A.2
Azria, D.3
Ozsahin, M.4
-
12
-
-
33748188459
-
Epidermal growth factor receptor biology in head and neck cancer
-
S. Kalyankrishna, and J.R. Grandis Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 24 2006 2666 2672
-
(2006)
J Clin Oncol
, vol.24
, pp. 2666-2672
-
-
Kalyankrishna, S.1
Grandis, J.R.2
-
13
-
-
0037115674
-
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma
-
K.K. Ang, B.A. Berkey, and X. Tu et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356
-
(2002)
Cancer Res
, vol.62
, pp. 7350-7356
-
-
Ang, K.K.1
Berkey, B.A.2
Tu, X.3
-
14
-
-
34250155320
-
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer
-
S. Temam, H. Kawaguchi, and A.K. El-Naggar et al. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer J Clin Oncol 25 2007 2164 2170
-
(2007)
J Clin Oncol
, vol.25
, pp. 2164-2170
-
-
Temam, S.1
Kawaguchi, H.2
El-Naggar, A.K.3
-
15
-
-
0032478998
-
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
-
J. Rubin Grandis, M.F. Melhem, and W.E. Gooding et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival J Natl Cancer Inst 90 1998 824 832
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 824-832
-
-
Rubin Grandis, J.1
Melhem, M.F.2
Gooding, W.E.3
-
16
-
-
33748653109
-
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas
-
C.H. Chung, K. Ely, and L. Mc Gavran et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas J Clin Oncol 24 2006 4170 4176
-
(2006)
J Clin Oncol
, vol.24
, pp. 4170-4176
-
-
Chung, C.H.1
Ely, K.2
Mc Gavran, L.3
-
17
-
-
84876232194
-
Cetuximab: Its unique place in head and neck cancer treatment
-
P. Specenier, and J.B. Vermorken Cetuximab: its unique place in head and neck cancer treatment Biologics 7 2013 77 90
-
(2013)
Biologics
, vol.7
, pp. 77-90
-
-
Specenier, P.1
Vermorken, J.B.2
-
18
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
J.A. Bonner, P.M. Harari, and J. Giralt et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
-
(2006)
N Engl J Med
, vol.354
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
19
-
-
0037429725
-
The ErbB receptors and their role in cancer progression
-
T. Holbro, G. Civenni, and N.E. Hynes The ErbB receptors and their role in cancer progression Exp Cell Res 284 2003 99 110
-
(2003)
Exp Cell Res
, vol.284
, pp. 99-110
-
-
Holbro, T.1
Civenni, G.2
Hynes, N.E.3
-
22
-
-
84979673540
-
Molecular pathways in head and neck cancer
-
10.1200/EdBook-AM.2013.33.246 [Epub ahead of print]
-
A. Psyrri, T.Y. Seiwert, and A. Jimeno Molecular pathways in head and neck cancer Am Soc Clin Oncol Educ Book 2013 2013 246 255 10.1200/EdBook-AM. 2013.33.246 [Epub ahead of print]
-
(2013)
Am Soc Clin Oncol Educ Book
, vol.2013
, pp. 246-255
-
-
Psyrri, A.1
Seiwert, T.Y.2
Jimeno, A.3
-
23
-
-
0028926718
-
The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes
-
S.W. Straight, B. Herman, and D.J. McCance The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes J Virol 69 1995 3185 3192
-
(1995)
J Virol
, vol.69
, pp. 3185-3192
-
-
Straight, S.W.1
Herman, B.2
McCance, D.J.3
-
24
-
-
0031818511
-
The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT
-
K. Crusius, E. Auvinen, and B. Steuer et al. The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT Exp Cell Res 241 1998 76 83
-
(1998)
Exp Cell Res
, vol.241
, pp. 76-83
-
-
Crusius, K.1
Auvinen, E.2
Steuer, B.3
-
25
-
-
33646585409
-
Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt
-
S.H. Kim, Y.S. Juhnn, and S. Kang et al. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt Cell Mol Life Sci 63 2006 930 938
-
(2006)
Cell Mol Life Sci
, vol.63
, pp. 930-938
-
-
Kim, S.H.1
Juhnn, Y.S.2
Kang, S.3
-
26
-
-
15544381671
-
Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: This action is mediated through HPV-E6 in HPV-positive cancers
-
R.S. Mathur, and S.P. Mathur Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers Gynecol Oncol 97 2005 206 213
-
(2005)
Gynecol Oncol
, vol.97
, pp. 206-213
-
-
Mathur, R.S.1
Mathur, S.P.2
-
27
-
-
0033558283
-
Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas
-
D. Johnston, H. Hall, T.P. DiLorenzo, and B.M. Steinberg Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas Cancer Res 59 1999 968 974
-
(1999)
Cancer Res
, vol.59
, pp. 968-974
-
-
Johnston, D.1
Hall, H.2
Dilorenzo, T.P.3
Steinberg, B.M.4
-
28
-
-
0027474459
-
Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation
-
A. Vambutas, T.P. DiLorenzo, and B.M. Steinberg Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation Cancer Res 53 1993 910 914
-
(1993)
Cancer Res
, vol.53
, pp. 910-914
-
-
Vambutas, A.1
Dilorenzo, T.P.2
Steinberg, B.M.3
-
29
-
-
0035671825
-
Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma
-
G. Almadori, G. Cadoni, and P. Cattani et al. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma Clin Cancer Res 7 2001 3988 3993
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3988-3993
-
-
Almadori, G.1
Cadoni, G.2
Cattani, P.3
-
30
-
-
33947140297
-
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer
-
N. Reimers, H.U. Kasper, and S.J. Weissenborn et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 2007 1731 1738
-
(2007)
Int J Cancer
, vol.120
, pp. 1731-1738
-
-
Reimers, N.1
Kasper, H.U.2
Weissenborn, S.J.3
-
31
-
-
49249095295
-
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
-
B. Kumar, K.G. Cordell, and J.S. Lee et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 2008 3128 3137
-
(2008)
J Clin Oncol
, vol.26
, pp. 3128-3137
-
-
Kumar, B.1
Cordell, K.G.2
Lee, J.S.3
-
32
-
-
77954213063
-
Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer
-
A. Hong, T. Dobbins, and C.S. Lee et al. Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer Eur J Cancer 46 2010 2088 2096
-
(2010)
Eur J Cancer
, vol.46
, pp. 2088-2096
-
-
Hong, A.1
Dobbins, T.2
Lee, C.S.3
-
33
-
-
65449131740
-
The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas
-
C.S. Kong, B. Narasimhan, and H. Cao et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 74 2009 553 561
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 553-561
-
-
Kong, C.S.1
Narasimhan, B.2
Cao, H.3
-
34
-
-
33845297649
-
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma
-
F. Perrone, S. Suardi, and E. Pastore et al. Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma Clin Cancer Res 12 2006 6643 6651
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6643-6651
-
-
Perrone, F.1
Suardi, S.2
Pastore, E.3
-
35
-
-
84876746241
-
EGFR and phosphorylated EGFR in relation to HPV and clinical outcome in tonsillar cancer
-
M. Romanitan, A. Näsman, and E. Munck-Wikland et al. EGFR and phosphorylated EGFR in relation to HPV and clinical outcome in tonsillar cancer Anticancer Res 33 2013 1575 1583
-
(2013)
Anticancer Res
, vol.33
, pp. 1575-1583
-
-
Romanitan, M.1
Näsman, A.2
Munck-Wikland, E.3
-
36
-
-
84881219523
-
Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype
-
10.1093/annonc/mdt013. Epub
-
T. Rampias, E. Pectasides, and M. Prasad et al. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype Ann Oncol 24 2013 2124 2131 10.1093/annonc/mdt013. Epub
-
(2013)
Ann Oncol
, vol.24
, pp. 2124-2131
-
-
Rampias, T.1
Pectasides, E.2
Prasad, M.3
-
37
-
-
77952492682
-
Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area
-
J.N. Al-Swiahb, C.C. Huang, and F.M. Fang et al. Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area Arch Otolaryngol Head Neck Surg 136 2010 502 508
-
(2010)
Arch Otolaryngol Head Neck Surg
, vol.136
, pp. 502-508
-
-
Al-Swiahb, J.N.1
Huang, C.C.2
Fang, F.M.3
-
38
-
-
84864115182
-
HPV specific testing: A requirement for oropharyngeal squamous cell carcinoma patients
-
M. Robinson, A. Schache, P. Sloan, and S. Thavaraj HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients Head Neck Pathol 6 Suppl. 1 2012 S83 S90
-
(2012)
Head Neck Pathol
, vol.6
, Issue.SUPPL. 1
-
-
Robinson, M.1
Schache, A.2
Sloan, P.3
Thavaraj, S.4
-
39
-
-
84864117690
-
P16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma
-
J.S. Lewis Jr. P16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma Head Neck Pathol 6 Suppl. 1 2012 S75 S82
-
(2012)
Head Neck Pathol
, vol.6
, Issue.SUPPL. 1
-
-
Lewis, Jr.J.S.1
-
40
-
-
79958069417
-
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma
-
R.J. Young, D. Rischin, and R. Fisher et al. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma Cancer Epidemiol Biomarkers Prev 20 2011 1230 1237
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 1230-1237
-
-
Young, R.J.1
Rischin, D.2
Fisher, R.3
-
41
-
-
33847648000
-
HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation
-
S.H. Kim, B.S. Koo, and S. Kang et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation Int J Cancer 120 2007 1418 1425
-
(2007)
Int J Cancer
, vol.120
, pp. 1418-1425
-
-
Kim, S.H.1
Koo, B.S.2
Kang, S.3
-
42
-
-
0029831041
-
Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
-
J.R. Grandis, M.F. Melhem, and E.L. Barnes et al. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck Cancer 78 1996 1284 1292
-
(1996)
Cancer
, vol.78
, pp. 1284-1292
-
-
Grandis, J.R.1
Melhem, M.F.2
Barnes, E.L.3
-
43
-
-
0024405695
-
TGF-alpha and EGF-receptor mRNAs in human oral cancers
-
R. Todd, B.R. Donoff, and R. Gertz et al. TGF-alpha and EGF-receptor mRNAs in human oral cancers Carcinogenesis 10 1989 1553 1556
-
(1989)
Carcinogenesis
, vol.10
, pp. 1553-1556
-
-
Todd, R.1
Donoff, B.R.2
Gertz, R.3
-
44
-
-
33748188459
-
Epidermal growth factor receptor biology in head and neck cancer
-
S. Kalyankrishna, and J.R. Grandis Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 24 2006 2666 2672
-
(2006)
J Clin Oncol
, vol.24
, pp. 2666-2672
-
-
Kalyankrishna, S.1
Grandis, J.R.2
-
45
-
-
0034600339
-
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
-
M.L. Gillison, W.M. Koch, and R.B. Capone et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 709-720
-
-
Gillison, M.L.1
Koch, W.M.2
Capone, R.B.3
-
46
-
-
2942731838
-
Role of human papillomavirus in the development of head and neck squamous cell carcinomas
-
H.C. Hafkamp, J.J. Manni, and E.J. Speel Role of human papillomavirus in the development of head and neck squamous cell carcinomas Acta Otolaryngol 124 2004 520 526
-
(2004)
Acta Otolaryngol
, vol.124
, pp. 520-526
-
-
Hafkamp, H.C.1
Manni, J.J.2
Speel, E.J.3
-
47
-
-
0035575774
-
Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas
-
J.P. Klussmann, S.J. Weissenborn, and U. Wieland et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas Cancer 92 2001 2875 2884
-
(2001)
Cancer
, vol.92
, pp. 2875-2884
-
-
Klussmann, J.P.1
Weissenborn, S.J.2
Wieland, U.3
-
48
-
-
68949201629
-
Activating and resistance mutations of EGFR in non-small-cell lung cancer: Role in clinical response to EGFR tyrosine kinase inhibitors
-
A.F. Gazdar Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors Oncogene 28 Suppl. 1 2009 S24 S31
-
(2009)
Oncogene
, vol.28
, Issue.SUPPL. 1
-
-
Gazdar, A.F.1
-
49
-
-
27544503230
-
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
-
N. Thatcher, A. Chang, and P. Parikh et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) Lancet 366 2005 1527 1537
-
(2005)
Lancet
, vol.366
, pp. 1527-1537
-
-
Thatcher, N.1
Chang, A.2
Parikh, P.3
-
50
-
-
22044445517
-
National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer
-
F.A. Shepherd, J. Rodrigues Pereira, and T. Ciuleanu et al. National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 2005 123 132
-
(2005)
N Engl J Med
, vol.353
, pp. 123-132
-
-
Shepherd, F.A.1
Rodrigues Pereira, J.2
Ciuleanu, T.3
-
51
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
T.J. Lynch, D.W. Bell, and R. Sordella et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
-
52
-
-
4444344330
-
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
-
W. Pao, V. Miller, and M. Zakowski et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci U S A 101 2004 13306 13311
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 13306-13311
-
-
Pao, W.1
Miller, V.2
Zakowski, M.3
-
53
-
-
2342624080
-
EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
-
J.G. Paez, P.A. Jänne, and J.C. Lee et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
-
(2004)
Science
, vol.304
, pp. 1497-1500
-
-
Paez, J.G.1
Jänne, P.A.2
Lee, J.C.3
-
54
-
-
69949186250
-
Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer
-
R. Rosell, T. Moran, and C. Queralt et al. Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 2009 958 967
-
(2009)
N Engl J Med
, vol.361
, pp. 958-967
-
-
Rosell, R.1
Moran, T.2
Queralt, C.3
-
55
-
-
28844501639
-
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
-
H. Shigematsu, and A.F. Gazdar Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers Int J Cancer 118 2006 257 262
-
(2006)
Int J Cancer
, vol.118
, pp. 257-262
-
-
Shigematsu, H.1
Gazdar, A.F.2
-
56
-
-
73449096114
-
Frequency of and variables associated with the EGFR mutation and its subtypes
-
T. Tanaka, M. Matsuoka, and A. Sutani et al. Frequency of and variables associated with the EGFR mutation and its subtypes Int J Cancer 126 2010 651 655
-
(2010)
Int J Cancer
, vol.126
, pp. 651-655
-
-
Tanaka, T.1
Matsuoka, M.2
Sutani, A.3
-
57
-
-
84860328097
-
Resistance to EGFR inhibitors: Molecular determinants and the enigma of head and neck cancer
-
L.G. Morris, and T.A. Chan Resistance to EGFR inhibitors: molecular determinants and the enigma of head and neck cancer Oncotarget 2 2011 894 895
-
(2011)
Oncotarget
, vol.2
, pp. 894-895
-
-
Morris, L.G.1
Chan, T.A.2
-
58
-
-
28144437798
-
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR
-
E.E. Cohen, M.W. Lingen, and L.E. Martin et al. Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR Clin Cancer Res 11 2005 8105 8108
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8105-8108
-
-
Cohen, E.E.1
Lingen, M.W.2
Martin, L.E.3
-
59
-
-
20244389231
-
Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck
-
J.W. Lee, Y.H. Soung, and S.Y. Kim et al. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck Clin Cancer Res 11 2005 2879 2882
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2879-2882
-
-
Lee, J.W.1
Soung, Y.H.2
Kim, S.Y.3
-
60
-
-
33846609066
-
EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil
-
I.I. Na, H.J. Kang, and S.Y. Cho et al. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil Eur J Cancer 43 2007 520 526
-
(2007)
Eur J Cancer
, vol.43
, pp. 520-526
-
-
Na, I.I.1
Kang, H.J.2
Cho, S.Y.3
-
61
-
-
84860244031
-
Human papillomavirus and gene mutations in head and neck squamous carcinomas
-
P. Friedland, A. Thomas, and A. Naran et al. Human papillomavirus and gene mutations in head and neck squamous carcinomas ANZ J Surg 82 2012 362 366
-
(2012)
ANZ J Surg
, vol.82
, pp. 362-366
-
-
Friedland, P.1
Thomas, A.2
Naran, A.3
-
62
-
-
33750962024
-
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer
-
F.R. Hirsch, M. Varella-Garcia, and P.A. Bunn Jr. et al. Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer J Clin Oncol 24 2006 5034 5042
-
(2006)
J Clin Oncol
, vol.24
, pp. 5034-5042
-
-
Hirsch, F.R.1
Varella-Garcia, M.2
Bunn, Jr.P.A.3
-
63
-
-
22044453790
-
Erlotinib in lung cancer - Molecular and clinical predictors of outcome
-
M.S. Tsao, A. Sakurada, and J.C. Cutz et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome N Engl J Med 353 2005 133 144
-
(2005)
N Engl J Med
, vol.353
, pp. 133-144
-
-
Tsao, M.S.1
Sakurada, A.2
Cutz, J.C.3
-
64
-
-
49149127726
-
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy
-
F.R. Hirsch, R.S. Herbst, and C. Olsen et al. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy J Clin Oncol 26 2008 3351 3357
-
(2008)
J Clin Oncol
, vol.26
, pp. 3351-3357
-
-
Hirsch, F.R.1
Herbst, R.S.2
Olsen, C.3
-
65
-
-
84875734469
-
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies
-
L. Licitra, S. Störkel, and K.M. Kerr et al. Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies Eur J Cancer 49 2013 1161 1168
-
(2013)
Eur J Cancer
, vol.49
, pp. 1161-1168
-
-
Licitra, L.1
Störkel, S.2
Kerr, K.M.3
-
66
-
-
84879783298
-
EGFR-directed treatments in SCCHN
-
10.1016/S1470-2045(13)70215-8 pii: S1470-2045(13)70215-8. [Epub ahead of print]
-
E.E. Vokes, and T.Y. Seiwert EGFR-directed treatments in SCCHN Lancet Oncol 2013 10.1016/S1470-2045(13)70215-8 pii: S1470-2045(13)70215-8. [Epub ahead of print]
-
(2013)
Lancet Oncol
-
-
Vokes, E.E.1
Seiwert, T.Y.2
-
67
-
-
69949127786
-
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy
-
E. Martinelli, R. De Palma, M. Orditura, F. De Vita, and F. Ciardiello Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy Clin Exp Immunol 158 2009 1 9
-
(2009)
Clin Exp Immunol
, vol.158
, pp. 1-9
-
-
Martinelli, E.1
De Palma, R.2
Orditura, M.3
De Vita, F.4
Ciardiello, F.5
-
68
-
-
52649096967
-
Antibody-based therapy for solid tumors
-
L. Yan, K. Hsu, and R.A. Beckman Antibody-based therapy for solid tumors Cancer J 14 3 2008 178 183
-
(2008)
Cancer J
, vol.14
, Issue.3
, pp. 178-183
-
-
Yan, L.1
Hsu, K.2
Beckman, R.A.3
-
69
-
-
35948961556
-
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines
-
J.M. Roda, T. Joshi, and J.P. Butchar et al. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines Clin Cancer Res 13 2007 6419 6428
-
(2007)
Clin Cancer Res
, vol.13
, pp. 6419-6428
-
-
Roda, J.M.1
Joshi, T.2
Butchar, J.P.3
-
70
-
-
34548124985
-
Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: Implications for Cetuximab-mediated therapy in recurrent/metastatic disease
-
S. Bellone, G. Frera, and G. Landolfi et al. Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease Gynecol Oncol 106 2007 513 520
-
(2007)
Gynecol Oncol
, vol.106
, pp. 513-520
-
-
Bellone, S.1
Frera, G.2
Landolfi, G.3
-
71
-
-
84869507183
-
CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis
-
A.C. Jung, S. Guihard, and S. Krugell et al. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis Int J Cancer 132 2013 26 36
-
(2013)
Int J Cancer
, vol.132
, pp. 26-36
-
-
Jung, A.C.1
Guihard, S.2
Krugell, S.3
-
72
-
-
84872324199
-
Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer
-
10.1186/1471-2407-13-26
-
B. Pajares, J.M. Trigo, and M.D. Toledo et al. Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer BMC Cancer 13 2013 26 10.1186/1471-2407-13-26
-
(2013)
BMC Cancer
, vol.13
, pp. 26
-
-
Pajares, B.1
Trigo, J.M.2
Toledo, M.D.3
-
73
-
-
80255134559
-
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer
-
L. Koutcher, E. Sherman, and M. Fury et al. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 81 2011 915 922
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 915-922
-
-
Koutcher, L.1
Sherman, E.2
Fury, M.3
-
74
-
-
84897058115
-
Cisplatin (CDDP) and radiation (RT) versus cetuximab (C) and RT in the context of human papillomavirus (HPV) and P16 in the treatment of locally advanced head and neck cancer (LAHNC)
-
San Diego, CA, October 31-November 4 (abstr. 133)
-
Koutcher LD, Sherman EJ, Carlson D, et al. Cisplatin (CDDP) and radiation (RT) versus cetuximab (C) and RT in the context of human papillomavirus (HPV) and P16 in the treatment of locally advanced head and neck cancer (LAHNC). American society for radiation oncology annual meeting. San Diego, CA, October 31-November 4, 2010 (abstr. 133).
-
(2010)
American Society for Radiation Oncology Annual Meeting
-
-
Koutcher, L.D.1
Sherman, E.J.2
Carlson, D.3
-
75
-
-
80053368876
-
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC)
-
[2011 ASCO annual meeting proceedings (post-meeting ed.), vol. 29, No 15-suppl (May 20 Supplement)]
-
K.K. Ang, Q.E. Zhang, and D.I. Rosenthal et al. A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC) J Clin Oncol 2011 5500 [2011 ASCO annual meeting proceedings (post-meeting ed.), vol. 29, No 15-suppl (May 20 Supplement)]
-
(2011)
J Clin Oncol
, pp. 5500
-
-
Ang, K.K.1
Zhang, Q.E.2
Rosenthal, D.I.3
-
76
-
-
84879785532
-
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): An open-label phase 3 randomised trial
-
on behalf of the SPECTRUM investigators pii: S1470-2045(13)70181-5
-
J.B. Vermorken, J. Stöhlmacher-Williams, I. Davidenko on behalf of the SPECTRUM investigators Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial Lancet Oncol 2013 pii: S1470-2045(13)70181-5
-
(2013)
Lancet Oncol
-
-
Vermorken, J.B.1
Stöhlmacher-Williams, J.2
Davidenko, I.3
-
77
-
-
84872445077
-
A randomized, open-label, phase II study of afatinib (BIBW 2992) versus cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Final data
-
Phoenix, AZ, January 26
-
Seiwert T, Fayette J, Cupissol D, et al. A randomized, open-label, phase II study of afatinib (BIBW 2992) versus cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: final data. In: Presented at the multidisciplinary head and neck cancer symposium, Phoenix, AZ, January 26, 2012.
-
(2012)
Multidisciplinary Head and Neck Cancer Symposium
-
-
Seiwert, T.1
Fayette, J.2
Cupissol, D.3
-
78
-
-
79955481029
-
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
-
J. Farley, M.W. Sill, and M. Birrer et al. Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study Gynecol Oncol 121 2011 303 308
-
(2011)
Gynecol Oncol
, vol.121
, pp. 303-308
-
-
Farley, J.1
Sill, M.W.2
Birrer, M.3
-
79
-
-
80051551247
-
Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
-
A.D. Santin, M.W. Sill, and D.S. Mc Meekin et al. Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 122 2011 495 500
-
(2011)
Gynecol Oncol
, vol.122
, pp. 495-500
-
-
Santin, A.D.1
Sill, M.W.2
Mc Meekin, D.S.3
-
80
-
-
69449086850
-
A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study
-
R.J. Schilder, M.W. Sill, Y.C. Lee, and R. Mannel A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study Int J Gynecol Cancer 19 2009 929 933
-
(2009)
Int J Gynecol Cancer
, vol.19
, pp. 929-933
-
-
Schilder, R.J.1
Sill, M.W.2
Lee, Y.C.3
Mannel, R.4
-
81
-
-
51649085865
-
Platinum-based chemotherapy plus cetuximab in head and neck cancer
-
J.B. Vermorken, R. Mesia, and F. Rivera et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 2008 1116 1127
-
(2008)
N Engl J Med
, vol.359
, pp. 1116-1127
-
-
Vermorken, J.B.1
Mesia, R.2
Rivera, F.3
-
82
-
-
84866428094
-
Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma
-
H.S. Won, C.K. Jung, and S.H. Chun et al. Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma Oral Oncol 48 2012 985 990
-
(2012)
Oral Oncol
, vol.48
, pp. 985-990
-
-
Won, H.S.1
Jung, C.K.2
Chun, S.H.3
-
83
-
-
84871298461
-
Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma
-
H. Husain, A. Psyrri, and A. Markovic et al. Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma Laryngoscope 122 2012 2762 2768
-
(2012)
Laryngoscope
, vol.122
, pp. 2762-2768
-
-
Husain, H.1
Psyrri, A.2
Markovic, A.3
|